Superworth

Fortress Biotech EPS FBIO

Diluted earnings per share by quarter and over the last twelve months, from 2010.

Last 12 months, to Jun 30, 2026
$2.65
Latest quarter, Q2 FY26
−$0.08
−118% on a year earlier
Fiscal year 2025
−$0.12

Fortress Biotech's earnings per share was $2.65 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.08, down 118% on the same quarter a year before.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$0.12n/a
FY2024−$2.90n/a
FY2023−$9.11n/a
FY2022−$15.21n/a
FY2021−$11.85n/a
FY2020−$9.75n/a
FY2019−$10.50n/a
FY2018−$28.65n/a
FY2017−$24.75n/a
FY2016−$20.55n/a
FY2015−$18.45n/a
FY2014−$8.55n/a
FY2013−$18.60n/a
FY2012−$19.35n/a
FY2011−$110.25n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.08−118%$2.65
Q1 FY26$2.82n/a$3.18
Q4 FY25−$0.20n/a−$0.12
Q3 FY25$0.11n/a−$0.29
Q2 FY25$0.45n/a−$1.16
Q1 FY25−$0.48n/a−$2.34
Q4 FY24−$0.37n/a−$2.90
Q3 FY24−$0.76n/a−$3.58
Q2 FY24−$0.73n/a−$3.76
Q1 FY24−$1.04n/a−$6.68
Q4 FY23−$1.05n/a−$9.11
Q3 FY23−$0.94n/a−$12.56

Against its peers

Companies in Drug Manufacturers - General nearest Fortress Biotech's size, closest first, today.

CompanyEPS, 12 monthsGrowth
FBIOFortress Biotech$2.65
SPROSpero Therapeutics$0.11
LFVNLifevantage$0.40−46% a year
ATNMActinium Pharmaceuticals$0.36
NATRNatures Sunshine Products$1.01+36% a year
ARVNArvinas$0.16
PBYIPuma Biotechnology$0.52−47% a year
IRWDIronwood Pharmaceuticals$0.77
ZVRAZevra Therapeutics$0.93
CRMDCorMedix$2.13+184% a year
Peer median$0.52

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Fortress Biotech

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.